# Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product

> **NCT06426121** · — · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 394 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** test Aerobic/F Culture Vials
- **DIAGNOSTIC_TEST:** control Aerobic/F Culture Vials

## Key facts

- **NCT ID:** NCT06426121
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-26
- **Primary completion:** 2025-10-23
- **Final completion:** 2025-10-23
- **Target enrollment:** 394 (ACTUAL)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426121, "Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06426121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*